Experimental design strategies in the optimization and robustness testing of adsorptive stripping voltammetric conditions for kynurenic acid determination

被引:25
作者
Furlanetto, S [1 ]
Pinzauti, S [1 ]
Gratteri, P [1 ]
LaPorta, E [1 ]
Calzeroni, G [1 ]
机构
[1] UNIV FLORENCE,DIPARTIMENTO FARMACOL PRECLIN & CLIN,I-50134 FLORENCE,ITALY
关键词
adsorptive stripping voltammetry; chemometrics; experimental design; kynurenic acid determination; robustness testing; validation;
D O I
10.1016/S0731-7085(96)02029-8
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Experimental design was used for the optimization and robustness testing of an adsorptive stripping voltammetric procedure for kynurenic acid determination. The optimization of the peak height response proceeded through a screening phase (D-optimal design strategy) followed by a response surface study (Doehlert design) applied to the variables pH, pulse amplitude and stirring rate. An interaction between pH and stirring rate was pointed out. The optimized method was validated and the variation of factors that was expected to occur in practice was simulated in a robustness test. A composite fractional matrix for the evaluation of method robustness was used and pH emerged as the only critical factor. The linear range found applying the optimized conditions was 2.5 x 10(-9) to 2.5 x 10(-7) M and the calculated limit of detection was 1.72 x 10(-9) M. (C) 1997 Published by Elsevier Science B.V.
引用
收藏
页码:1585 / 1594
页数:10
相关论文
共 23 条
[1]   THE APPLICATION OF EXPERIMENTAL-DESIGN TO THE ROBUSTNESS TESTING OF A METHOD FOR THE DETERMINATION OF DRUG-RELATED IMPURITIES BY CAPILLARY ELECTROPHORESIS [J].
ALTRIA, KD ;
FILBEY, SD .
CHROMATOGRAPHIA, 1994, 39 (5-6) :306-310
[2]  
Atkinson A.C., 1992, OPTIMUM EXPT DESIGNS
[3]   DETERMINATION OF URINARY TRYPTOPHAN AND ITS METABOLITES ALONG THE NICOTINIC-ACID PATHWAY BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ULTRAVIOLET DETECTION [J].
BIZZARRI, M ;
CATIZONE, A ;
POMPEI, M ;
CHIAPPINI, L ;
CURINI, L ;
LAGANA, A .
BIOMEDICAL CHROMATOGRAPHY, 1990, 4 (01) :24-27
[4]   IDENTIFICATION AND MEASUREMENT OF KYNURENIC ACID IN THE RAT-BRAIN AND OTHER ORGANS [J].
CARLA, V ;
LOMBARDI, G ;
BENI, M ;
RUSSI, P ;
MONETI, G ;
MORONI, F .
ANALYTICAL BIOCHEMISTRY, 1988, 169 (01) :89-94
[5]  
Carlson R., 1992, Design and Optimization in Organic Synthesis
[6]   INHIBITORS OF KYNURENINE HYDROXYLASE AND KYNURENINASE INCREASE CEREBRAL FORMATION OF KYNURENATE AND HAVE SEDATIVE AND ANTICONVULSANT ACTIVITIES [J].
CARPENEDO, R ;
CHIARUGI, A ;
RUSSI, P ;
LOMBARDI, G ;
CARLA, V ;
PELLICCIARI, R ;
MORONI, F ;
MATTOLI, L .
NEUROSCIENCE, 1994, 61 (02) :237-244
[7]  
Deming SN., 1993, EXPT DESIGN CHEMOMET, DOI DOI 10.1016/j.plaphy.2010.08.016
[8]  
Frank I., 1994, Data analysis handbook
[9]   DESIGN AND OPTIMIZATION OF THE VARIABLES IN THE ADSORPTIVE STRIPPING VOLTAMMETRIC DETERMINATION OF RUFLOXACIN IN TABLETS, HUMAN PLASMA AND URINE [J].
FURLANETTO, S ;
GRATTERI, P ;
PINZAUTI, S ;
LEARDI, R ;
DREASSI, E ;
SANTONI, G .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1995, 13 (4-5) :431-438
[10]  
Gratteri P, 1996, FARMACO, V51, P231